Synthetic Cell Technology Could Benefit Vaccine Production, Venter Says
Executive SummaryJ. Craig Venter's synthetic cell may dramatically speed up vaccine production, he told a Congressional committee
You may also be interested in...
The former Celera CEO has raised $70 million for a new organization that will use genomic, biochemical and microbiome data to find stem cell-based treatments for aging-related disorders.